Ortin Global Limited (NSE:ORTINGLOBE)
16.71
-0.30 (-1.76%)
Jun 19, 2026, 3:22 PM IST
Ortin Global Revenue
In the fiscal year ending March 31, 2026, Ortin Global had annual revenue of 1.01M INR, down -70.66%. Ortin Global had revenue of 344.00K in the quarter ending March 31, 2026, a decrease of -24.06%.
Revenue
1.01M
Revenue Growth
-70.66%
P/S Ratio
133.58
Revenue / Employee
335.00K
Employees
3
Market Cap
134.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.01M | -2.42M | -70.66% |
| Mar 31, 2025 | 3.43M | -18.84M | -84.61% |
| Mar 31, 2024 | 22.26M | -38.08M | -63.11% |
| Mar 31, 2023 | 60.34M | -21.97M | -26.69% |
| Mar 31, 2022 | 82.31M | 633.62K | 0.78% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.86B |
| Balaxi Pharmaceuticals | 2.70B |
| Valiant Laboratories | 2.37B |
| Bafna Pharmaceuticals | 1.51B |
| Vaishali Pharma | 1.09B |
| Alpa Laboratories | 1.06B |
| Par Drugs and Chemicals | 1.04B |
| Vivimed Labs | 883.92M |